Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

OCCIDENT

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 37
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 21
Rounds per year 1.19
Lead investments 7
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.43
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Therapeutics
  • Medical
Summary

OCCIDENT is the famous VC, which was founded in 1993. The fund was located in Europe if to be more exact in Switzerland. The main office of represented VC is situated in the Zug.

The important activity for fund was in 2018. Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars.

The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Among the various public portfolio startups of the fund, we may underline advanceCOR, iThera Medical, Implandata Ophthalmic Products Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Diagnostics, Pharmaceutical.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the OCCIDENT, startups are often financed by Venture Kick, Zu00fcrcher Kantonal Bank, High-Tech Gru00fcnderfonds. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, High-Tech Gru00fcnderfonds, KfW. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, Eurostars, Alpana Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of OCCIDENT:
Typical Co-investors
OCCIDENT is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after OCCIDENT:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Antenna Group California, San Francisco, United States
Bodhtree Consulting Ltd California, Santa Clara, United States
BRANDED STRATEGIC ADVISORS New York, New York, United States
Bridge Investments -
CDAM England, London, United Kingdom
CN-Healthcare Beijing, China, Haidian
Falcon Partners New Jersey, Roseland, United States
Hatzimemos / Libby New York, New York, United States
ITC Holdings Michigan, Novi, United States
Jinyu Touzi China, Songjiang, Songjiang District
Jynwel Capital China, Hong Kong, Hong Kong Island
Nanjing Qingfang Touzi China, Jiangsu, Nanjing
RACSeedSpark -
Robolution Capital France, Ile-de-France, Paris
Southern Pacific Capital Group Florida, Melbourne, United States
Space Florida Florida, Merritt Island, United States
Stone-Goff Partners Boston, Massachusetts, United States
Undercurrent New York, New York, United States
W3 Digital Agency Argentina, Buenos Aires, Distrito Federal
Zijinhui Beijing, China, Haidian

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

hemotune

Biotechnology
Health Care
Life Science
Medical Device
Therapeutics
$15M25 Mar 2024 Zurich, Zurich, Switzerland

Tubulis

Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics
$151M14 Mar 2024 Munich, Bavaria, Germany

Altavo

$5M20 Feb 2024 Dresden, Sachsen, Germany

Chipmetrics

Electronics
Manufacturing
$2M24 Jan 2024 Joensuu, Eastern Finland, Finland

ReCatalyst

Chemical
Nanotechnology
$2M12 Jul 2023 Ljubljana, Ljubljana Urban Commune, Slovenia

EBAMed

Health Care
$16M27 Jun 2023 Geneva, Geneva, Switzerland

Resistell AG

Medical Device
$9M20 Dec 2022 Basel, Basel-City, Switzerland

Core Sensing

Electronic Design Automation (EDA)
Electronics
Sensor
$5M26 Sep 2022 Darmstadt, Hessen, Germany

Avelo

Manufacturing
Medical Device
$2M20 Sep 2022 Schlieren, Zurich, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent OCCIDENT?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 37
Average round size 14M
Rounds per year 1.19
Peak activity year 2018
Lead investments 7
Follow on index 0.43
Group Appearance index 0.95

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

hemotune

Biotechnology
Health Care
Life Science
Medical Device
Therapeutics
$15M25 Mar 2024 Zurich, Zurich, Switzerland

Tubulis

Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics
$151M14 Mar 2024 Munich, Bavaria, Germany

Altavo

$5M20 Feb 2024 Dresden, Sachsen, Germany

Chipmetrics

Electronics
Manufacturing
$2M24 Jan 2024 Joensuu, Eastern Finland, Finland

ReCatalyst

Chemical
Nanotechnology
$2M12 Jul 2023 Ljubljana, Ljubljana Urban Commune, Slovenia

EBAMed

Health Care
$16M27 Jun 2023 Geneva, Geneva, Switzerland

Resistell AG

Medical Device
$9M20 Dec 2022 Basel, Basel-City, Switzerland

Core Sensing

Electronic Design Automation (EDA)
Electronics
Sensor
$5M26 Sep 2022 Darmstadt, Hessen, Germany

Avelo

Manufacturing
Medical Device
$2M20 Sep 2022 Schlieren, Zurich, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: